Otsuka Pharmaceutical Development & Commercialization Issues Public Comment on FDA Notice
2020-07-25
zz-Public Comments2020-07-25
Targeted News Service
WASHINGTON, July 25 -- Karen Ragland, director of global regulatory intelligence at Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, New Jersey, has issued a public comment on . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 25 -- Karen Ragland, director of global regulatory intelligence at Otsuka Pharmaceutical Development and Commercialization Inc., Princeton, New Jersey, has issued a public comment on . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2020